Загрузка...
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
The recent spreading of new SARS-CoV-2 variants, carrying several mutations in the spike protein, could impact immune protection elicited by natural infection or conferred by vaccination. In this study, we evaluated the neutralizing activity against the viral variants that emerged in the United King...
Сохранить в:
| Опубликовано в: : | Viruses |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310013/ https://ncbi.nlm.nih.gov/pubmed/34372553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071347 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|